HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
-0.0010 (-40.00%)
Apr 25, 2024, 3:55 PM EDT - Market closed

HTG Molecular Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012
Net Income
-21.59-17.15-20.87-19.3-16.45-18.96-26.04-21.4-13.96-11.77
Upgrade
Depreciation & Amortization
0.590.721.351.741.471.241.470.660.50.32
Upgrade
Share-Based Compensation
0.811.381.811.2201.4410.410.180.09
Upgrade
Other Operating Activities
1.79-1.461.42-0.361.81-0.291.331.090.28-0.46
Upgrade
Operating Cash Flow
-18.41-16.51-16.29-16.7-13.17-16.57-22.23-19.24-13-11.82
Upgrade
Capital Expenditures
-0.02-0.64-0.45-1.1-0.95-1.02-1.95-1.34-0.86-0.78
Upgrade
Acquisitions
0.10.01-0.020000000
Upgrade
Change in Investments
-27.56-31.22-44.12-66.8-85.67-4.3-33.13-45.85--
Upgrade
Other Investing Activities
39.925.1963.3264.463.48.659.515--
Upgrade
Investing Cash Flow
12.42-6.6618.73-3.5-23.223.2824.42-32.18-0.86-0.78
Upgrade
Dividends Paid
0000000-4.5700
Upgrade
Common Stock Issued
9.0210.677.5520.7638.2819.91247.6500
Upgrade
Share Repurchases
-0-0-0-0000-000
Upgrade
Other Financing Activities
-0.41-0.271.5-1.37-0.15-4.160.038.0215.657.1
Upgrade
Financing Cash Flow
8.610.399.0519.3938.1315.752.0351.1115.657.1
Upgrade
Net Cash Flow
2.61-12.811.51-0.811.732.464.21-0.321.8-5.5
Upgrade
Free Cash Flow
-18.43-17.15-16.75-17.8-14.12-17.59-24.18-20.58-13.85-12.6
Upgrade
Free Cash Flow Margin
-289.51%-192.58%-195.88%-92.68%-65.68%-119.20%-471.11%-509.24%-416.18%-561.77%
Upgrade
Free Cash Flow Per Share
-20.73-29.68-43.42-84.09-92.37-298.82-611.91-819.91-7480.72-6803.95
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.